Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum 9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.

GREY:DGCRF - Post Discussion

9342-8530 Quebec Inc > Options @ $0.11
View:
Post by Dibah42 on Feb 06, 2015 7:51am

Options @ $0.11

Latest 10 SEDI filings (by transaction date) for CUR within the last 6 months [?]
Amended Filing
As of 11:59pm ET February 5th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 5/15 Feb 4/15 Simoneau, Jacques Direct Ownership Options 50 - Grant of options 23,723 $0.110
Feb 5/15 Feb 4/15 Zurawski, Vincent R. Direct Ownership Options 50 - Grant of options 18,978 $0.110
Feb 5/15 Feb 4/15 Sheldon, Andrew J. Direct Ownership Options 50 - Grant of options 18,978 $0.110
Feb 5/15 Feb 4/15 Proulx, Louise Direct Ownership Options 50 - Grant of options 23,723 $0.110
Feb 5/15 Feb 4/15 Fradet, Yves Direct Ownership Options 50 - Grant of options 50,000 $0.110
Feb 5/15 Feb 4/15 Boivin, Frederic Direct Ownership Options 50 - Grant of options 5,000 $0.110
Feb 5/15 Feb 4/15 Allard, Danielle Direct Ownership Options 50 - Grant of options 5,000 $0.110
Dec 16/14 Dec 16/14 Axelrod, Todd M. Indirect Ownership Common Shares 00 - Opening Balance-Initial SEDI Report 1,156,500
Dec 16/14 Dec 16/14 Axelrod, Todd M. Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report 7,402,500
Nov 3/14 Nov 1/14 Zurawski, Vincent R. Direct Ownership Options 52 - Expiration of options -20,000 $4.23
Comment by RetailRube on Feb 17, 2015 9:49pm
This is like a Sherlock Holmes mystery in which a major clue was a dog that didn't bark. In the long list of people receiving stock options at 11 cents, Bordeleau is missing.  He received zero options.  Does that mean he is no longer associated with Diagnocure?  I read the entire MD&A but didn't see him mentioned. It is also surprising that the very low stock ...more  
Comment by Dibah42 on Feb 20, 2015 4:28pm
Senior Executive in Residence or now Senior Phantom in residence?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities